| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Samuel E Navarro last filed a Form 4 in December 2021, as Director at STEX. The filings on record cover 2 companies. Samuel E Navarro's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 155,000 shares of STEX. Net of sales, the STEX filings show accumulation of 3,500 shares.
Samuel E Navarro has 19 Form 4 filings on record from September 2015 to December 2021, across 2 companies: Director at Streamex (STEX), 2019–2021; Director at STRATA Skin Sciences (SSKN), 2015–2020.
The 24 reported transactions were 9 option or other derivative awards, 7 open-market purchases, 4 stock awards and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $64K and no sales.
The largest open-market purchase was 20,000 shares of SSKN at an average $2.01 on June 5, 2018, about $40K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.